Fortress Biotech Inc expected to post a loss of 23 cents a share - Earnings Preview

Fortress Biotech

04/08/2023 12:10

* Fortress Biotech Inc  FBIO.OQ   FBIO.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 7
(estimated). 
    * The Bay Harbor Islands Florida-based  company is expected
to
report  a 7.5% decrease in revenue to $17.465 million from
$18.89 million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Fortress Biotech
Inc is
for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fortress
Biotech
Inc is $5​, above​ its last closing price of $0.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.23       -0.20      -0.21     Missed  -5
 Dec. 31 2023  -0.23       -0.22      -0.30     Missed  -32.2
 Sep. 30 2022  -0.21       -0.27      -0.25     Beat    7.4​
 Jun. 30 2022  -0.22       -0.21      -0.24     Missed  -14.3
 ​​Mar.        -0.26       -0.28      -0.18     Beat    35.7
 31 2022                                                
 Dec. 31 2021  -0.14       0.18       -0.38     Missed  -315.9
                                                        ​
 Sep. 30 2021  -0.08       -0.08      -0.14     Missed  -71.4
 Jun. 30 2021  -0.15       -0.12      -0.29     Missed  -132
 This summary was machine generated August 4 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated